[Federal Register Volume 85, Number 134 (Monday, July 13, 2020)]
[Notices]
[Pages 41985-41986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0081]
Advisory Committee on Immunization Practices (ACIP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
CDC, announces the following meeting of the Advisory Committee on
Immunization Practices (ACIP). This meeting is open to the public. Time
will be available for public comment. The meeting will be webcast live
via the World Wide Web.
DATES: The meeting will be held on July 29, 2020, from 10 a.m. to 4
p.m., EDT (times subject to change).
Written comments must be received on or before July 30, 2020.
ADDRESSES: For more information on ACIP please visit the ACIP website:
http://www.cdc.gov/vaccines/acip/index.html.
You may submit comments, identified by Docket No. CDC-2020-0081, by
either of the following methods below. CDC does not accept comment by
email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Docket No. CDC-2020-0081, c/o Attn: July ACIP
Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H24-8, Atlanta, GA 30329-4027.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
[[Page 41986]]
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road, NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Matters To Be Considered: The agenda will include discussions on
COVID-19 vaccines. No recommendation votes are scheduled. Agenda items
are subject to change as priorities dictate. For more information on
the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web; for more information on ACIP please visit the ACIP website:
http://www.cdc.gov/vaccines/acip/index.html.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Comments received
are part of the public record and are subject to public disclosure. Do
not include any information in your comment or supporting materials
that you consider confidential or inappropriate for public disclosure.
If you include your name, contact information, or other information
that identifies you in the body of your comments, that information will
be on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket. CDC does not accept comment by email.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the July ACIP meeting must submit a request
at http://www.cdc.gov/vaccines/acip/meetings/ no later than 11:59 p.m.,
EDT, July 22, 2020 according to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by July 23, 2020. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: Written comments must be received on or
before July 30, 2020. Written public comments submitted by 72 hours
prior to the ACIP meeting will be provided to ACIP members before the
meeting.
This notice is being published less than 15 days prior to the
meeting due to the public health emergency declared on January 27,
2020. There is a critical need for this committee to discuss urgent
matters related to discussions on COVID-19 vaccines and be actively
engaged in the national response efforts as dictated by circumstances
and events. In the interest of promoting openness and transparency, we
are publishing a late notice in the Federal Register to inform the
public.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-15178 Filed 7-9-20; 3:00 pm]
BILLING CODE 4163-18-P